Efficacy of 5% dextrose prolotherapy compared with saline injections for chondromalacia patella: A randomized controlled trial
PM&R · 2026
DOI: 10.1002/pmrj.70119 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PM&R, 2026. Verfasst von Yunus Burak Bayır und 2 weiteren Autor:innen. Beteiligte Einrichtung: Etlik City Hospital, Physical Therapy and Rehabilitation Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Glucose, Prolotherapy, Saline Solution, Chondromalacia Patellae. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Objective
To investigate the efficacy of 5% dextrose prolotherapy applied to patients with chondromalacia patella.
Design
This 2‐arm, double‐blinded, prospective, randomized controlled interventional study in a single center included 54 patients with knee pain ongoing for at least 3 months. The patients were randomly assigned to a dextrose prolotherapy group (DPG) or a saline group (SG). Periarticular 5% dextrose prolotherapy or saline injections were applied to these groups, respectively, at 0, 3, and 6 weeks. The outcome measures were Visual Analog Scale (VAS), Patellofemoral Pain Severity Scale (PPSS), Kujala Patellofemoral Scoring System (KPSS), and the Short Form‐36 (SF‐36) at baseline and at the end of the 3rd, 6th, and 24th weeks.
Results
A total of 54 patients were included, with 27 in each group. After the withdrawal of 2, evaluation was made of 52 patients. Compared to baseline values, the VAS, PPSS scores, and number of tender points significantly decreased ( p < .001 for all), and the KPSS and SF‐36 scores increased at the end of weeks 3, 6, and 24 in both groups ( p = .003 for the SF‐36 mental health subscale and p < .001 in all other evaluations). At 24 weeks, in the DPG compared to SG, VAS was 1.67 points lower (95% CI: −2.57 to −7.80; p < .001), PPSS was 15.4 points lower (95% CI: −23.6 to −7.18; p < .001), KPSS was 9.3 points higher (95% CI: 5.3–13.2; p < .001), the number of tender points was 0.79 points lower (95% CI: −1.4 to −0.12; p < .021), and the physical function SF‐36 subscale was 7.8 points higher (95% CI: 3.6–12.7; p < .001).
Conclusion
In patients with chondromalacia patella, 5% dextrose prolotherapy reduced pain and improved symptoms, functional status, and quality of life more effectively than saline injections. Therefore, 5% dextrose prolotherapy can be recommended as an effective treatment option.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Etlik City Hospital, Physical Therapy and Rehabilitation Hospital, Ankara, Turkey.
- Memorial Ankara Hospital, Ankara, Turkey.
- Department of Physical Rehabilitation Medicine, Health Sciences University, Gulhane School of Medicine, Ankara, Turkey.
ORCID-Profile: Yunus Burak Bayır
Zitieren
APA
Bayır, Y. B., Köroğlu, Ö., & Demir, Y. (2026). Efficacy of 5% dextrose prolotherapy compared with saline injections for chondromalacia patella: A randomized controlled trial. PM&R. https://doi.org/10.1002/pmrj.70119
Vancouver
Bayır YB, Köroğlu Ö, Demir Y. Efficacy of 5% dextrose prolotherapy compared with saline injections for chondromalacia patella: A randomized controlled trial. PM&R. 2026. doi:10.1002/pmrj.70119
BibTeX
@article{Bayr2026,
author = {Bayır, Yunus Burak and Köroğlu, Özlem and Demir, Yasin},
title = {Efficacy of 5% dextrose prolotherapy compared with saline injections for chondromalacia patella: A randomized controlled trial},
journal = {PM&R},
year = {2026},
doi = {10.1002/pmrj.70119}
}
EUVIMED